Medicine News and Research

RSS

New consortium for scaled up meat produced from cultivated cells

Competition promotes innovation, but for a nascent industry, one strategy is for competitors to band together to tackle fundamental technical obstacles, set standards, and exchange knowledge in a way that benefits the industry as a whole.

20 Oct 2022

New gene linked to the growth of colon cancer discovered

Researchers at Mount Sinai’s Tisch Cancer Institute have discovered a new gene that is crucial to the development of colon cancer and established that inflammation in the region surrounding the tumor can contribute to the development of tumor cells.

20 Oct 2022

Innovative method opens myriad new avenues for understanding the biology behind COVID-19

A highly innovative method using the latest technology has generated a comprehensive list of SARS-CoV-2 viral and human proteins that interact with each other, with one such interaction showing the virus directly influencing proteins that regulate the human immune system.

18 Oct 2022

Nonconducting W434F mutant varies in structure and conformation

Potassium (K+) channels are tiny, highly specialized conduits found in every live cell that transfer K+ ions in an exceedingly selective and quick manner across cell membranes.

13 Oct 2022

A more efficient way to deliver gene therapies to the CNS

For gene therapy, the blood-brain barrier (BBB) poses a formidable obstacle. The BBB, which is made up of cells that are closely packed together, prevents poisons and pathogens from accessing brain tissue while also blocking potential treatments for diseases that impact the CNS.

12 Oct 2022

Adults with congenital blindness experience striking recoveries of night vision after gene therapy

Adults with a genetic form of childhood-onset blindness experienced striking recoveries of night vision within days of receiving an experimental gene therapy, according to researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.

11 Oct 2022

UC Davis launches new center to accelerate the development of promising cancer therapies

UC Davis Comprehensive Cancer Center has launched a Center for Experimental Therapeutics in Cancer to accelerate promising cancer therapies from the lab to the bedside.

From The University of California, Davis 10 Oct 2022

Broadening the scope of CRISPR-Cas9 genome editing systems

A group of Northwestern University researchers has created a novel gene editing platform that might influence the future application of a nearly infinite library of CRISPR-based therapeutics.

7 Oct 2022

Spores integrate environmental signals over time

When exposed to starvation and stress, certain bacteria enter a dormant state in which life functions cease. These cells, known as spores, can resist punishing extremes of heat, pressure, and even the extreme conditions of outer space by entering a profound hibernation.

7 Oct 2022

Cell illumination and targeted cell editing using RNA-based editing technology

An RNA-based editing tool has been developed by Duke University researchers, which targets specific cells rather than genes. Any cell type can be precisely targeted, and any protein of interest can be added only to that cell type.

6 Oct 2022

Microbiome manipulation to prevent and cure diseases

Tagbo Niepa, assistant professor of chemical engineering at the University of Pittsburgh, is inspired by this possibility in his research. His work on using the microbiome to enhance human health was recognized with a $2 million New Innovator Award from the National Institutes of Health, which funds “exceptionally creative scientists proposing high-risk, high-impact research.”

From University of Pittsburgh 5 Oct 2022

Research team outlines three-step technique that lets human body defend against Hep B

A team from the University of Geneva (UNIGE) has unraveled the precise operation of this defensive mechanism after finding a crucial protein complex that is active when our body is infected by the virus, paving the path for novel treatment targets.

5 Oct 2022

The strategy used by metastatic cancer cells to invade the liver identified

The alternative pathway for liver metastasis has been revealed by a team of researchers.

5 Oct 2022

Research shows readily available pharmaceutical manufacturing capacity in the United States

President Joe Biden signed an executive order Sept. 12 to launch a National Biotechnology and Biomanufacturing Initiative, noting the United States relies too heavily on foreign materials and foreign bioproduction.

5 Oct 2022

Newly isolated Bacteroides likely to be present in mammals beyond mice

In the DFG-funded Collaborative Research Center (CRC) 1182 “Origin and Function of Metaorganisms,” scientists from Kiel University and the Max Planck Institute for Evolutionary Biology in Plön (MPI-EB) are investigating the evolutionary history and function of Bacteroides.

From The Max Planck Institute 30 Sep 2022

New guidelines to generate high-quality, well-structured organoids

Researchers have opened a new avenue for investigations of neurological development, disease, and therapies that cannot be undertaken in living people by employing stem cells to grow small brain-like structures in the lab.

30 Sep 2022

Transforming “tissue engineering” into a reality

The National Institute of Biomedical Imaging and Bioengineering awarded Case Western Reserve $6.1 million to develop body tissue engineering.

29 Sep 2022

“Junk” DNA could provide access to innovative treatments for neurological conditions

The breakthrough study from the University of Sheffield’s Neuroscience Institute and Healthy Lifespan Institute offers critical new insights into the so-called junk DNA, or DNA that was previously believed to be unimportant to the coding of the genome, and how it affects neurological disorders like Motor Neuron Disease (MND) and Alzheimer’s.

29 Sep 2022

Highly effective and safe Zika vaccine technology

Scientists from the University of California, Los Angeles (UCLA) have discovered a Zika vaccine technology that is very safe and effective in preclinical mouse models.

29 Sep 2022

New insights into the regulatory mechanisms of cell fate decisions

The Babraham Institute’s Reik lab’s study has improved the understanding of the function of DNA methylation during the early stages of development.

29 Sep 2022

Medicine News and Research

New consortium for scaled up meat produced from cultivated cells

New gene linked to the growth of colon cancer discovered

Innovative method opens myriad new avenues for understanding the biology behind COVID-19

Nonconducting W434F mutant varies in structure and conformation

A more efficient way to deliver gene therapies to the CNS

Adults with congenital blindness experience striking recoveries of night vision after gene therapy

UC Davis launches new center to accelerate the development of promising cancer therapies

Broadening the scope of CRISPR-Cas9 genome editing systems

Spores integrate environmental signals over time

Cell illumination and targeted cell editing using RNA-based editing technology

Microbiome manipulation to prevent and cure diseases

Research team outlines three-step technique that lets human body defend against Hep B

The strategy used by metastatic cancer cells to invade the liver identified

Research shows readily available pharmaceutical manufacturing capacity in the United States

Newly isolated Bacteroides likely to be present in mammals beyond mice

New guidelines to generate high-quality, well-structured organoids

Transforming “tissue engineering” into a reality

“Junk” DNA could provide access to innovative treatments for neurological conditions

Highly effective and safe Zika vaccine technology

New insights into the regulatory mechanisms of cell fate decisions

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics